Aihc Capital Management Limited
Aihc Capital Management Limited is an exempt reporting adviser based in Central, Hong Kong, Hong Kong that reports managing 1 hedge fund on Form ADV. Its private funds, of all types, hold $332.0 million in gross assets. Its disclosed U.S. stock holdings returned an estimated +88.6% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +88.6% from Q1 2026 to Q2 2026, compared with +9.5% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- —Form ADV Item 5.F
- Gross assets of private funds
- $332.0 millionAll private fund types, Form ADV
- Hedge funds managed
- 11 private funds in total
- Employees
- —Form ADV Item 5.A
- Registration
- Exempt reporting adviserCRD 310459
- Latest Form ADV
- 03/30/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q2 2026 | +57.7% | +14.8% |
| Q1 2026 | +19.6% | -4.6% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Largest disclosed holdings
- Revolution Medicines Inc$56.8 million
- Oric Pharmaceuticals Inc$41.5 million
- I Mab$5.6 million
- Korro Bio Inc$398,893
As of 2026-06-30, from 13F filing by AIHC Capital Management Ltd.
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. HedgeMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures